X4 Pharmaceuticals, Inc (XFOR) KPIs and segments
Close on Nov 13, 2026Market cap $309.34MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive X4 Pharmaceuticals's business
X4 Pharmaceuticals's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
License and other revenue($M) | 6.43 | 0.24 | 0.30 | 0.20 | 0.23 | 27.9 | 0 | 0 | 0 | 0 | |
Product revenue, net($M) | 2.37 | 2.47 | 2.27 | 1.57 | 1.74 | 0.94 | 1.43 | 0.56 | 0.56 | 0 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-06.
See a number that looks wrong?